Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
1993 • 4,650 citations
A predictive model for aggressive non-Hodgkin's lymphoma
1993 • 3,483 citations
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
1992 • 1,198 citations
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
1995 • 1,043 citations
Analysis of survival by tumor response.
1983 • 1,021 citations
Analysis of survival by tumor response.
1986 • 1,018 citations
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.
1998 • 979 citations
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
1993 • 683 citations
Statistical validation of intermediate endpoints for chronic diseases
1992 • 629 citations
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
1997 • 582 citations
The validation of surrogate endpoints in meta-analyses of randomized experiments
2000 • 545 citations
ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER
1997 • 483 citations
Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy
1995 • 446 citations
Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal Cancer
1996 • 440 citations
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
1998 • 416 citations
Treatment of Non-Hodgkin's Lymphoma
1993 • 387 citations
Food and Drug Administration requirements for approval of new anticancer drugs.
1985 • 237 citations
Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
2001 • 199 citations
Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer
1994 • 193 citations
Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.
1994 • 188 citations
Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids research
1994 • 167 citations
ON THE RELATIONSHIP BETWEEN RESPONSE TO TREATMENT AND SURVIVAL TIME
1996 • 130 citations
Statistical challenges in the evaluation of surrogate endpoints in randomized trials
2002 • 128 citations
Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report
1980 • 117 citations
Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trials
1983 • 76 citations
The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer
1994 • 74 citations
Reporting Results From Chemotherapy Trials
1984 • 68 citations
Faster Access to Drugs for Serious or Life-Threatening Illnesses Through use of the Accelerated Approval Regulation in the United States
1998 • 13 citations